Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Lawrence S. Olanoff"'
Autor:
James M. Anderson, Lawrence S. Olanoff
Publikováno v:
Medical Applications of Controlled Release ISBN: 9780429276620
Sustained and/or controlled release of biological agents is a concept that has received a great deal of attention during the past decade. Systems designed to release drugs at a rate directly influenced by the nature of their surrounding environment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e30c8b70891ce5abc897551467678b
https://doi.org/10.1201/9780429276620-11
https://doi.org/10.1201/9780429276620-11
Autor:
Steven R. Pollock, Lawrence S. Olanoff
Publikováno v:
Journal of Controlled Release. 11:331-341
Clinical pharmacology evaluation plays a unique and vital role in the design of novel drug delivery systems. The purpose of this review is to describe how clinical pharmacology principles and methodologies can be applied to the study and development
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 92:88-91
The patency rate of internal mammary artery grafts is reported to be better than that of saphenous vein grafts in myocardial revascularization operations. To identify a possible biochemical explanation for this phenomenon, we studied the production o
Publikováno v:
Journal of Pharmaceutical Sciences. 68:1147-1150
A membrane-controlled drug delivery device was developed to release tetracycline at zero-order rates. The tetracycline delivery vehicle is a trilaminate disk consisting of core and coating membranes fabricated from a series of 2-hydroxyethyl methacry
Publikováno v:
British Journal of Clinical Pharmacology. 22:317-323
The objective of this study was to determine the relationships between the total oral clearance of propranolol and the partial clearances through its primary metabolic pathways, i.e. glucuronidation, side-chain oxidation and ring oxidation. Seven you
Autor:
Richard E. Gibson, Lawrence S. Olanoff
Publikováno v:
Journal of Controlled Release. 6:361-366
Intranasal absorption has been demonstrated for various drugs, including peptidic compounds, under a wide range of delivery conditions. However, little is known of the physicochemical nature of the nasal mucosal membrane and how specific changes in t
Publikováno v:
Clinical Pharmacology and Therapeutics. 44:225-231
The buccal absorption of flurbiprofen was studied in normal men to quantify the transport from the oral cavity in humans and to evaluate the closed—perfusion cell apparatus as a means to study drug transport across externally accessible biologic me
Autor:
Perry V. Halushka, Lawrence S. Olanoff, H. David Reines, Mitchell F. Hollon, Thomas M. Fuhrman
Publikováno v:
Journal of Surgical Research. 42:284-289
Metabolites of arachidonic acid, particularly thromboxanes, have been implicated as mediators of lung injury. The formation of thromboxane A2 can be decreased by glucocorticoid steroids by inhibiting the enzyme phospholipase A2 or by ibuprofen which
Publikováno v:
Clinical Pharmacology and Therapeutics. 37:391-395
Levels of thromboxane B2 (TxB2), the stable metabolite of thromboxane A2, are elevated in human and experimental septic shock. The thromboxane synthetase inhibitor dazoxiben has improved survival and decreased pulmonary hypertension in experimental e
Publikováno v:
Clinical Pharmacology and Therapeutics. 35:755-761
Our objective was to determine the kinetics of (+)- and (-)-propranolol after intravenous doses of racemic drug. Five normal subjects received 0.1 mg/kg of a pseudoracemate of propranolol that consisted of deuterium-labeled (+)-propranolol and unlabe